STUGERON Tablet (2018)
Active ingredients: Cinnarizine
Product Name and Form
Stugeron 15 mg tablets.
White circular tablet with S/15 on one side and JANSSEN on the other side.
Qualitative and Quantitative Composition
Each tablet contains 15 mg cinnarizine.
Excipients with known effect: Each tablet contains 160 mg lactose monohydrate and 15 mg sucrose.
For the full list of excipients, see section 6.1.
Cinnarizine has been shown to be a non-competitive antagonist of the smooth muscle contractions caused by various vasoactive agents including histamine. Cinnarizine also acts on vascular smooth muscle by selectively inhibiting the calcium influx into depolarised cells, thereby reducing the availability of free Ca2+ ions for the induction and maintenance of contraction.
Pack sizes and Marketing
PVC/Aluminium foil blisters
Polystyrene tubs with polyethylene caps
Each pack containing 15, 25, 100, 250 or 1000 tablets.
Not all pack sizes may be marketed.
Janssen-Cilag Limited, 50-100 Holmers Farm Way, High Wycombe, Buckinghamshire, HP12 4EG, UK
Date of first authorisation: 14 September 1989
Date of latest renewal: 21 August 2001